Rosetta Genomics signs test validation pact
This article was originally published in Clinica
Executive Summary
Israeli firm Rosetta Genomics has signed an agreement with the University of California, Irvine's school of medicine to develop and validate diagnostics based on Rosetta's microRNA technology.